TY - JOUR A1 - Groeber, Florian A1 - Engelhardt, Lisa A1 - Lange, Julia A1 - Kurdyn, Szymon A1 - Schmid, Freia F. A1 - Rücker, Christoph A1 - Mielke, Stephan A1 - Walles, Heike A1 - Hansmann, Jan T1 - A First Vascularized Skin Equivalent as an Alternative to Animal Experimentation JF - ALTEX - Alternatives to Animal Experimentation N2 - Tissue-engineered skin equivalents mimic key aspects of the human skin, and can thus be employed as wound coverage for large skin defects or as in vitro test systems as an alternative to animal models. However, current skin equivalents lack a functional vasculature limiting clinical and research applications. This study demonstrates the generation of a vascularized skin equivalent with a perfused vascular network by combining a biological vascularized scaffold (BioVaSc) based on a decellularized segment of a porcine jejunum and a tailored bioreactor system. Briefly, the BioVaSc was seeded with human fibroblasts, keratinocytes, and human microvascular endothelial cells. After 14 days at the air-liquid interface, hematoxylin & eosin and immunohistological staining revealed a specific histological architecture representative of the human dermis and epidermis including a papillary-like architecture at the dermal-epidermal-junction. The formation of the skin barrier was measured non-destructively using impedance spectroscopy. Additionally, endothelial cells lined the walls of the formed vessels that could be perfused with a physiological volume flow. Due to the presence of a complex in-vivo-like vasculature, the here shown skin equivalent has the potential for skin grafting and represents a sophisticated in vitro model for dermatological research. KW - alternative to animal testing KW - skin equivalents KW - tissue engineering KW - vascularization Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-164438 VL - 33 IS - 4 ER - TY - JOUR A1 - Thibaudeau, Laure A1 - Taubenberger, Anna V. A1 - Holzapfel, Boris M. A1 - Quent, Verena M. A1 - Fuehrmann, Tobias A1 - Hesami, Parisa A1 - Brown, Toby D. A1 - Dalton, Paul D. A1 - Power, Carl A. A1 - Hollier, Brett G. A1 - Hutmacher, Dietmar W. T1 - A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone JF - Disease Models & Mechanisms N2 - The skeleton is a preferred homing site for breast cancer metastasis. To date, treatment options for patients with bone metastases are mostly palliative and the disease is still incurable. Indeed, key mechanisms involved in breast cancer osteotropism are still only partially understood due to the lack of suitable animal models to mimic metastasis of human tumor cells to a human bone microenvironment. In the presented study, we investigate the use of a human tissue-engineered bone construct to develop a humanized xenograft model of breast cancer-induced bone metastasis in a murine host. Primary human osteoblastic cell-seeded melt electrospun scaffolds in combination with recombinant human bone morphogenetic protein 7 were implanted subcutaneously in non-obese diabetic/severe combined immunodeficient mice. The tissue-engineered constructs led to the formation of a morphologically intact 'organ' bone incorporating a high amount of mineralized tissue, live osteocytes and bone marrow spaces. The newly formed bone was largely humanized, as indicated by the incorporation of human bone cells and human-derived matrix proteins. After intracardiac injection, the dissemination of luciferase-expressing human breast cancer cell lines to the humanized bone ossicles was detected by bioluminescent imaging. Histological analysis revealed the presence of metastases with clear osteolysis in the newly formed bone. Thus, human tissue-engineered bone constructs can be applied efficiently as a target tissue for human breast cancer cells injected into the blood circulation and replicate the osteolytic phenotype associated with breast cancer-induced bone lesions. In conclusion, we have developed an appropriate model for investigation of species-specific mechanisms of human breast cancer-related bone metastasis in vivo. KW - breast cancer KW - bone metastasis KW - humanized xenograft model KW - melt electrospinning KW - tissue engineering KW - osteotropism KW - in vivo KW - stem-cell niche KW - human prostate-cancer KW - morphogenetic protein KW - osteoprogenitor cells KW - endochondral ossification KW - mouse model KW - trabecular bone KW - calcium phosphate KW - skeletal metastases Y1 - 2014 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-117466 VL - 7 IS - 2 ER - TY - THES A1 - Hochleitner, Gernot T1 - Advancing melt electrospinning writing for fabrication of biomimetic structures T1 - Entwicklung des Melt Electrospinning Writing zur Erzeugung biomimetischer Strukturen N2 - In order to mimic the extracellular matrix for tissue engineering, recent research approaches often involve 3D printing or electrospinning of fibres to scaffolds as cell carrier material. Within this thesis, a micron fibre printing process, called melt electrospinning writing (MEW), combining both additive manufacturing and electrospinning, has been investigated and improved. Thus, a unique device was developed for accurate process control and manufacturing of high quality constructs. Thereby, different studies could be conducted in order to understand the electrohydrodynamic printing behaviour of different medically relevant thermoplastics as well as to characterise the influence of MEW on the resulting scaffold performance. For reproducible scaffold printing, a commonly occurring processing instability was investigated and defined as pulsing, or in extreme cases as long beading. Here, processing analysis could be performed with the aim to overcome those instabilities and prevent the resulting manufacturing issues. Two different biocompatible polymers were utilised for this study: poly(ε-caprolactone) (PCL) as the only material available for MEW until then and poly(2-ethyl-2-oxazoline) for the first time. A hypothesis including the dependency of pulsing regarding involved mass flows regulated by the feeding pressure and the electrical field strength could be presented. Further, a guide via fibre diameter quantification was established to assess and accomplish high quality printing of scaffolds for subsequent research tasks. By following a combined approach including small sized spinnerets, small flow rates and high field strengths, PCL fibres with submicron-sized fibre diameters (fØ = 817 ± 165 nm) were deposited to defined scaffolds. The resulting material characteristics could be investigated regarding molecular orientation and morphological aspects. Thereby, an alignment and isotropic crystallinity was observed that can be attributed to the distinct acceleration of the solidifying jet in the electrical field and by the collector uptake. Resulting submicron fibres formed accurate but mechanically sensitive structures requiring further preparation for a suitable use in cell biology. To overcome this handling issue, a coating procedure, by using hydrophilic and cross-linkable star-shaped molecules for preparing fibre adhesive but cell repellent collector surfaces, was used. Printing PCL fibre patterns below the critical translation speed (CTS) revealed the opportunity to manufacture sinusoidal shaped fibres analogously to those observed using purely viscous fluids falling on a moving belt. No significant influence of the high voltage field during MEW processing could be observed on the buckling phenomenon. A study on the sinusoidal geometry revealed increasing peak-to-peak values and decreasing wavelengths as a function of decreasing collector speeds sc between CTS > sc ≥ 2/3 CTS independent of feeding pressures. Resulting scaffolds printed at 100 %, 90 %, 80 % and 70 % of CTS exhibited significantly different tensile properties, foremost regarding Young’s moduli (E = 42 ± 7 MPa to 173 ± 22 MPa at 1 – 3 % strain). As known from literature, a changed morphology and mechanical environment can impact cell performance substantially leading to a new opportunity of tailoring TE scaffolds. Further, poly(L-lactide-co-ε-caprolactone-co-acryloyl carbonate) as well as poly(ε-caprolactone-co-acryloyl carbonate) (PCLAC) copolymers could be used for MEW printing. Those exhibit the opportunity for UV-initiated radical cross-linking in a post-processing step leading to significantly increased mechanical characteristics. Here, single fibres of the polymer composed of 90 mol.% CL and 10 mol.% AC showed a considerable maximum tensile strength of σmax = 53 ± 16 MPa. Furthermore, sinusoidal meanders made of PCLAC yielded a specific tensile stress-strain characteristic mimicking the qualitative behaviour of tendons or ligaments. Cell viability by L929 murine fibroblasts and live/dead staining with human mesenchymal stem cells revealed a promising biomaterial behaviour pointing out MEW printed PCLAC scaffolds as promising choice for medical repair of load-bearing soft tissue. Indeed, one apparent drawback, the small throughput similar to other AM methods, may still prevent MEW’s industrial application yet. However, ongoing research focusses on enlargement of manufacturing speed with the clear perspective of relevant improvement. Thereby, the utilisation of large spinneret sizes may enable printing of high volume rates, while downsizing the resulting fibre diameter via electrical field and mechanical stretching by the collector uptake. Using this approach, limitations of FDM by small nozzle sizes could be overcome. Thinking visionary, such printing devices could be placed in hospitals for patient-specific printing-on-demand therapies one day. Taking the evolved high deposition precision combined with the unique small fibre diameter sizes into account, technical processing of high performance membranes, filters or functional surface finishes also stands to reason. N2 - Um biomimetische extrazelluläre Matrices für das Tissue Engineering herzustellen, bedienen sich aktuelle Forschungsansätze oftmals der Produktion von Faser-Konstrukten durch additive Fertigung oder Elektrospinn-Verfahren. Das sogenannte Melt Electrospinning Writing (MEW) kombiniert Vorteile beider Techniken und weist dadurch ein hohes Applikationspotential auf. Daher bestand das Ziel der vorliegenden Arbeit in der Weiterentwicklung und Erforschung des MEW. Für diesen Zweck wurde eine neuartige Forschungsanlage konzipiert und gebaut, welche mit einzigartiger Verfahrenspräzision und Prozesskontrolle die Fertigung von hochqualitativen Konstrukten ermöglichte. Auf Basis dessen konnten die durchgeführten Studien das Verständnis des elektrohydrodynamischen Druckvorgangs und der untersuchten Prozessparameter vertiefen und letztendlich zur Ausweitung des Verfahrens auf neue medizinisch relevante Thermoplaste beitragen. Um eine reproduzierbare Herstellung von Scaffolds zu ermöglichen, wurde eine häufig auftretende Prozessinstabilität erforscht und als pulsing, oder in stark ausgeprägten Fällen als long beading, klassifiziert. Durch Prozessanalyse konnte zudem eine Methode zur Vermeidung dieser Instabilität entwickelt werden. Dafür wurden zwei unterschiedliche biokompatible Polymere verwendet: Poly(ε-Caprolacton) (PCL) als bis dahin einziger verfügbarer MEW Werkstoff, sowie erstmalig Poly(2-Ethyl-2-Oxazolin). Die aufgestellte Hypothese umfasst eine universelle Abhängigkeit der pulsing Instabilität zu involvierten Massenströmen, welche durch Anpassung des angelegten Prozessdruckes und der elektrischen Feldstärke reguliert werden kann. Um ein optimales Prozessergebnis für nachfolgende Forschungsarbeiten zu erzielen, wurde zusätzlich ein Leitfaden zur quantitativen Bewertung des Grades der Instabilität bereitgestellt. Durch Kombination kleiner Spinndüsen, kleiner Schmelze-Flussraten und hoher elektrischen Feldstärken, konnten erstmalig PCL Fasern mit sub-mikron Durchmessern (fØ = 817 ± 165 nm) zu präzisen Scaffolds verarbeitet werden. Diese wurden anschließend durch materialwissenschaftliche Analytik charakterisiert. Dabei wurde eine molekulare Vorzugsorientierung und isotrope Kristallausrichtung entlang der Faser beobachtet, welche durch den hohen Verstreckungsgrad des erstarrenden Polymerstrahls erklärt werden konnte. Resultierende sub-mikron Fasern konnten zwar für einen akkuraten Druckvorgang verwendet werden, jedoch erwiesen sich die Strukturen als instabil und daher nicht geeignet für die Handhabung bei Zellkulturstudien. Aus diesem Grund wurde ein Beschichtungsansatz mittels hydrophilen und vernetzbaren Sternmolekülen für Substratflächen herangezogen. Während solche modifizierten Oberflächen bekanntermaßen Zelladhäsion verhindern, konnten gedruckte sub-mikron Scaffolds auf der Oberfläche haften und so für biologische Studien verwendet werden. Durch das gezielte Ablegen von Fasern unterhalb der kritischen Translationsgeschwindigkeit (CTS) des Kollektors, konnten sinusförmige Faserstrukturen erzeugt werden. Analog zu rein viskosen Fluiden, welche durch ein bewegliches Band aufgesammelt werden, schien dieser Vorgang dem sogenannten buckling zu unterliegen und daher phänomenologisch nicht oder nur geringfügig vom elektrischen Feld abhängig zu sein. Zudem konnte eine durchgeführte Studie die direkte Abhängigkeit der Fasergeometrie mit der Kollektorbewegung belegen. Unabhängig vom Prozessdruck, führte eine verminderte Kollektorgeschwindigkeit sc in den Grenzen CTS > sc ≥ 2/3 CTS zu erhöhten Amplituden bzw. Spitze-zu-Spitze Werten und verkürzten Wellenlängen. Durch das kontrollierte Ablegen der Fasern bei Geschwindigkeiten von 100 %, 90 % 80 % und 70 % CTS konnten zudem Scaffolds mit unterschiedlichen mechanischen Eigenschaften hergestellt werden. Speziell der Zugmodul wurde dadurch etwa um eine halbe Größenordnung moduliert (Es = 42 ± 7 MPa bis 173 ± 22 MPa bei 1 – 3 % Dehnung). Dies ist in Kombination mit der Strukturierung für maßgeschneiderte TE Scaffolds von großem Interesse, da zelluläre Systeme sensibel auf ihre Umgebung reagieren können. Des Weiteren wurden Poly(L-Lactid-co-ε-Caprolacton-co-Acryloylcarbonat) und Poly(ε-Caprolacton-co-Acryloylcarbonat) (PCLAC) Copolymere hinsichtlich deren MEW Verarbeitbarkeit untersucht. Solche Kunststoffe können nach dem Druckvorgang mit UV-Strahlung radikalisch vernetzt werden und dadurch deutlich erhöhte mechanische Eigenschaften ausbilden. Für Fasern aus 90 mol.% CL und 10 mol.% AC wurden beispielsweise maximale Zugfestigkeiten von σmax = 53 ± 16 MPa ermittelt. MEW gedruckte sinusförmige Faserstrukturen aus PCLAC wiesen darüber hinaus ein biomimetisches Spannungs-Dehnung-Verhalten auf, vergleichbar zu Sehnen- und Ligamentgewebe. Eine Untersuchung der Zellviabilität von L929 murinen Fibroblasten im Eluattest, sowie eine lebend/tot-Färbung von humanen mesenchymalen Stammzellen auf den Scaffolds, ergab vielversprechende Resultate und damit ein relevantes Anwendungspotential solcher Strukturen als Implantat. Neben genannten Vorteilen, weist MEW als Verfahren bislang allerdings geringe Produktionsgeschwindigkeiten auf. Diese sind daher in den Fokus aktueller Forschungsvorhaben gerückt. Einen Ansatz hierfür bieten Spinndüsen mit hohem Innendurchmesser und erhöhter Austragsrate, wobei die optimierte elektrische Feldstärke, sowie ein Verstrecken durch die Kollektorbewegung, zu den erwünschten dünnen Fasern führen können. Dadurch kann die abwärtslimitierte Düsengröße des FDM Verfahrens überwunden werden. Visionär gedacht, könnte eine solche Anlage direkt in Krankenhäusern zur Fertigung von patienten- und defektspezifischen Implantaten eingesetzt werden. Darüber hinaus ermöglicht die hohe Präzision, zusammen mit dem Drucken von Mikro-Fasern, einen technischen Einsatz zur Herstellung von Membranen, Filtern oder funktionalen Oberflächenbeschichtungen. KW - scaffold KW - polymer KW - 3D printing KW - additive manufacturing KW - melt electrospinning KW - melt electrowriting KW - tissue engineering KW - polymer processing Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-162197 ER - TY - JOUR A1 - Pereira, A. R. A1 - Trivanović, D. A1 - Herrmann, M. T1 - Approaches to mimic the complexity of the skeletal mesenchymal stem/stromal cell niche in vitro JF - European Cells and Materials N2 - Mesenchymal stem/stromal cells (MSCs) are an essential element of most modern tissue engineering and regenerative medicine approaches due to their multipotency and immunoregulatory functions. Despite the prospective value of MSCs for the clinics, the stem cells community is questioning their developmental origin, in vivo localization, identification, and regenerative potential after several years of far-reaching research in the field. Although several major progresses have been made in mimicking the complexity of the MSC niche in vitro, there is need for comprehensive studies of fundamental mechanisms triggered by microenvironmental cues before moving to regenerative medicine cell therapy applications. The present comprehensive review extensively discusses the microenvironmental cues that influence MSC phenotype and function in health and disease – including cellular, chemical and physical interactions. The most recent and relevant illustrative examples of novel bioengineering approaches to mimic biological, chemical, and mechanical microenvironmental signals present in the native MSC niche are summarized, with special emphasis on the forefront techniques to achieve bio-chemical complexity and dynamic cultures. In particular, the skeletal MSC niche and applications focusing on the bone regenerative potential of MSC are addressed. The aim of the review was to recognize the limitations of the current MSC niche in vitro models and to identify potential opportunities to fill the bridge between fundamental science and clinical application of MSCs. KW - Mesenchymal stem/stromal cells KW - skeletal progenitor cells KW - niche KW - in vitro models KW - bone KW - tissue engineering Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-268823 SN - 1473-2262 VL - 37 ER - TY - THES A1 - Scheller, Katharina T1 - Charakterisierung und Anwendung von humanen, primären mikrovaskulären Endothelzellen mit erweiterter Proliferationsfähigkeit T1 - Characterization and application of human primary microvascular endothelial cells with extended proliferation capacity N2 - Das Arbeitsgebiet Tissue Engineering befasst sich mit der Klärung der Mechanismen, die der Funktionen verschiedener Gewebearten zu Grunde liegen sowie mit der Entwicklung alternativer Strategien zur Behandlung von Organversagen bzw. Organverlusten. Einer der kritischsten Punkte im Tissue Engineering ist die ausreichende Versorgung der Zellen mit Nährstoffen und Sauerstoff. Bioartifizielle Gewebe mit einer Dicke von bis zu 200 µm können mittels Diffusion ausreichend versorgt werden. Für dickere Transplantate ist die Versorgung der Zellen alleine durch Diffusion jedoch nicht gegeben. Hierfür müssen Mechanismen und Strategien zur Prävaskularisierung der artifiziellen Gewebekonstrukte entwickelt werden, damit die Nährstoff- und Sauerstoffversorgung aller Zellen, auch im Inneren des Transplantates, von Anfang an gewährleistet ist. Eine wichtige Rolle bei der Prävaskularisierung spielt die Angiogenese. Dabei ist die Wahl einer geeigneten Zellquelle entscheidend, da die Zellen die Basis für die Angiogenese darstellen. Mikrovaskuläre Endothelzellen (mvEZ) sind maßgeblich an der Angiogenese beteiligt. Das Problem bei der Verwendung von humanen primären mvEZ ist ihre geringe Verfügbarkeit, ihre limitierte Proliferationskapazität und der schnelle Verlust ihrer typischen Endothelzellmarker in-vitro. Der Aufbau standardisierter in-vitro Testsysteme ist durch die geringe Zellausbeute auch nicht möglich. Die upcyte® Technologie bietet hierfür einen Lösungsansatz. In der vorliegenden Arbeit konnten upcyte® mvEZ als Alternative zu primären mvEZ generiert werden. Es konnte gezeigt werden, dass die Zellen eine erweiterte Proliferationsfähigkeit aufweisen und im Vergleich zu primären mvEZ durchschnittlich 15 zusätzliche Populationsverdopplungen leisten können. Dadurch ist es möglich 3x104-fach mehr upcyte® mvEZ eines Spenders zu generieren verglichen mit den korrespondierenden Primärzellen. Die gute und ausreichende Verfügbarkeit der Zellen macht sie interessant für die Standardisierung von in-vitro Testsystemen, ebenso können die Zellen zur Prävaskularisierung von Transplantaten eingesetzt werden. Upcyte® mvEZ zeigen zahlreiche Primärzellmerkmale, die in der Literatur beschrieben sind. Im konfluenten Zustand zeigen sie die für primäre mvEZ spezifische pflastersteinartige Morphologie. Darüber hinaus exprimieren upcyte® mvEZ typische Endothelzellmarker wie CD31, vWF, eNOS, CD105, CD146 und VEGFR-2 vergleichbar zu primären mvEZ. Eine weitere endothelzellspezifische Eigenschaft ist die Bindung von Ulex europaeus agglutinin I Lektin an die alpha-L-Fucose enthaltene Kohlenhydratstrukturen von mvEZs. Auch hier wurden upcyte® Zellen mit primären mvEZ verglichen und zeigten die hierfür charkteristischen Strukturen. Zusätzlich zu Morphologie, Proliferationskapazität und endothelzellspezifischen Markern, zeigen upcyte® mvEZ auch mehrere funktionelle Eigenschaften, welche in primären mvEZ beobachtet werden können, wie beispielsweise die Aufnahme von Dil-markiertem acetyliertem Low Density Lipoprotein (Dil-Ac-LDL) oder die Fähigkeit den Prozess der Angiognese zu unterstützen. Zusätzlich bilden Sphäroide aus upcyte® mvEZ dreidimensionale luminäre Zellformationen in einer Kollagenmatrix aus. Diese Charakteristika zeigen den quasi-primären Phänotyp der upcyte® mvEZs. Upcyte® mvEZ stellen darüber hinaus eine neuartige mögliche Zellquelle für die Generierung prävaskularisierter Trägermaterialien im Tissue Engineering dar. In der vorliegenden Arbeit konnte die Wiederbesiedlung der biologisch vaskularisierte Matrix (BioVaSc) mit upcyte® mvEZ vergleichbar zu primären mvEZ gezeigt werden. Der Einsatz von upcyte® mvEZ in der BioVaSc stellt einen neuen, vielversprechenden Ansatz zur Herstellung eines vaskularisierten Modells für Gewebekonstrukte dar, wie beispielsweise einem Leberkonstrukt. Zusammenfassend konnte in der vorliegenden Arbeit gezeigt werden, dass upcyte® mvEZ vergleichbar zu primären mvEZs sind und somit eine geeignete Alternative für die Generierung prävaskulierter Trägermaterialien und Aufbau von in-vitro Testsystemen darstellen. Darüber hinaus wurde ein neues, innovatives System für die Generierung einer perfundierten, mit Endothelzellen wiederbesiedelten Matrix für künstliches Gewebe in-vitro entwickelt. N2 - The scope of tissue engineering includes researching mechanisms underlying the function of different types of tissue, as well as the development of alternative strategies for the treatment of organ failure or organ loss. One of the critical aspects of tissue engineering is the adequate supply of cells with nutrition and oxygen. Bioartificial tissue up to a thickness of 200µm can be supplied sufficiently via diffusion. For thicker transplants, the supply of cells, only via diffusion is not sufficient. For this purpose, mechanisms and strategies for pre-vascularization of artificial tissue constructs need to be developed in order to ensure the supply of nutrition and oxygen to the inside of a transplant from the beginning. An important part of pre-vascularization is angiogenesis. Thereby, the selection of a suitable cell source is crucial, as these cells form the basis of angiogenesis. Microvascular endothelial cells (mvEC) are an important part of angiogenesis. Using human primary mvEC is critical due to the quick loss of their endothelial cell marker in-vitro but their limited availability and capacity of proliferation presents a problem. Additionally, the number of cells is also not sufficient for setup a standardized in-vitro test system. Upcyte® technology provides an approach to solving this problem. This work focused on the generation of upcyte® mvEC as alternative to primary mvEC. It was shown that cells treated with upcyte® technology have an enhanced capability of proliferation, resulting in 15 additional population doublings, compared to primary mvEC. Thus, it is possible to generate 3x104-fold more upcyte® mvEC from one donor compared to corresponding primary cells. The sufficient cell availability is important for the standardization of in-vitro test systems, as well as the usage for pre-vascularization of transplants. Upcyte® mvEC show many primary cell-like characteristics, which are described in literature. In the confluent state, upcyte® mvEC show a primary cell-specific cobblestone-like morphology. Furthermore, upcyte® mvEC express typical endothelial cell markers, such as CD31, vWF, eNOS, CD105, CD146 and VEGFR-2, at a similar level to primary mvEZ. An additional endothelial cell-specific attribute is the linkage of Ulex europaeus agglutinin I lectin to carbohydrate-structures of mvEC, which contain alpha-L-fucose. These data showed that there was a good comparison between the characteristics of upcyte® and primary mvEC. In addition to morphology, proliferation capacity and endothelial cell-specific markers, upcyte® mvEC showed functional characteristics, which are also observed in primary mvEC. Examples include the uptake of Dil-marked acetylated low density lipoprotein (Dil-Ac-LDL) and the ability to support the process of angiogenesis. In addition, spheroids formed from upcyte® mvEC formed three dimensional luminal cell formations in a collagen matrix. These characteristics show the quasi-phenotype of upcyte® mvEC. Upcyte® mvEC also represents a new promising cell source for the generation of pre-vascularized scaffolds in the tissue engineering context. The use of upcyte® mvEC in BioVaSc represents a promising new approach for producing a model for vascularized tissue constructs, such as a liver constructs. In summary, this work focussed on the development of upcyte® mvEC which were shown to be comparable to primary mvEC and therefore represent a sufficient and reliable alternative cell source for the generation of pre-vascularized scaffolds and the construction of in-vitro test systems. Moreover, a new and innovative system for the generation of a perfusable, endothelialized matrix for artificial tissue in-vitro has been developed. KW - Tissue Engineering KW - Angiogenese KW - Endothelzellen KW - Tissue Engineering KW - Angiogenese KW - Endothelial cells KW - tissue engineering KW - angiogenesis Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-76577 ER - TY - JOUR A1 - Wagenbrenner, Mike A1 - Mayer-Wagner, Susanne A1 - Rudert, Maximilian A1 - Holzapfel, Boris Michael A1 - Weissenberger, Manuel T1 - Combinations of hydrogels and mesenchymal stromal cells (MSCs) for cartilage tissue engineering — a review of the literature JF - Gels N2 - Cartilage offers limited regenerative capacity. Cell-based approaches have emerged as a promising alternative in the treatment of cartilage defects and osteoarthritis. Due to their easy accessibility, abundancy, and chondrogenic potential mesenchymal stromal cells (MSCs) offer an attractive cell source. MSCs are often combined with natural or synthetic hydrogels providing tunable biocompatibility, biodegradability, and enhanced cell functionality. In this review, we focused on the different advantages and disadvantages of various natural, synthetic, and modified hydrogels. We examined the different combinations of MSC-subpopulations and hydrogels used for cartilage engineering in preclinical and clinical studies and reviewed the effects of added growth factors or gene transfer on chondrogenesis in MSC-laden hydrogels. The aim of this review is to add to the understanding of the disadvantages and advantages of various combinations of MSC-subpopulations, growth factors, gene transfers, and hydrogels in cartilage engineering. KW - hydrogels KW - osteoarthritis KW - cartilage defects KW - MSCs KW - cartilage regeneration KW - tissue engineering Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-250177 SN - 2310-2861 VL - 7 IS - 4 ER - TY - JOUR A1 - Al-Hejailan, Reem A1 - Weigel, Tobias A1 - Schürlein, Sebastian A1 - Berger, Constantin A1 - Al-Mohanna, Futwan A1 - Hansmann, Jan T1 - Decellularization of full heart — optimizing the classical sodium-dodecyl-sulfate-based decellularization protocol JF - Bioengineering N2 - Compared to cell therapy, where cells are injected into a defect region, the treatment of heart infarction with cells seeded in a vascularized scaffold bears advantages, such as an immediate nutrient supply or a controllable and persistent localization of cells. For this purpose, decellularized native tissues are a preferable choice as they provide an in vivo-like microenvironment. However, the quality of such scaffolds strongly depends on the decellularization process. Therefore, two protocols based on sodium dodecyl sulfate or sodium deoxycholate were tailored and optimized for the decellularization of a porcine heart. The obtained scaffolds were tested for their applicability to generate vascularized cardiac patches. Decellularization with sodium dodecyl sulfate was found to be more suitable and resulted in scaffolds with a low amount of DNA, a highly preserved extracellular matrix composition, and structure shown by GAG quantification and immunohistochemistry. After seeding human endothelial cells into the vasculature, a coagulation assay demonstrated the functionality of the endothelial cells to minimize the clotting of blood. Human-induced pluripotent-stem-cell-derived cardiomyocytes in co-culture with fibroblasts and mesenchymal stem cells transferred the scaffold into a vascularized cardiac patch spontaneously contracting with a frequency of 25.61 ± 5.99 beats/min for over 16 weeks. The customized decellularization protocol based on sodium dodecyl sulfate renders a step towards a preclinical evaluation of the scaffolds. KW - tissue engineering KW - decellularization KW - vascularized scaffold KW - cardiac patch KW - dynamic culture Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-270781 SN - 2306-5354 VL - 9 IS - 4 ER - TY - JOUR A1 - Hrynevich, Andrei A1 - Achenbach, Pascal A1 - Jungst, Tomasz A1 - Brook, Gary A. A1 - Dalton, Paul D. T1 - Design of Suspended Melt Electrowritten Fiber Arrays for Schwann Cell Migration and Neurite Outgrowth JF - Macromolecular Bioscience N2 - In this study, well-defined, 3D arrays of air-suspended melt electrowritten fibers are made from medical grade poly(ɛ-caprolactone) (PCL). Low processing temperatures, lower voltages, lower ambient temperature, increased collector distance, and high collector speeds all aid to direct-write suspended fibers that can span gaps of several millimeters between support structures. Such processing parameters are quantitatively determined using a “wedge-design” melt electrowritten test frame to identify the conditions that increase the suspension probability of long-distance fibers. All the measured parameters impact the probability that a fiber is suspended over multimillimeter distances. The height of the suspended fibers can be controlled by a concurrently fabricated fiber wall and the 3D suspended PCL fiber arrays investigated with early post-natal mouse dorsal root ganglion explants. The resulting Schwann cell and neurite outgrowth extends substantial distances by 21 d, following the orientation of the suspended fibers and the supporting walls, often generating circular whorls of high density Schwann cells between the suspended fibers. This research provides a design perspective and the fundamental parametric basis for suspending individual melt electrowritten fibers into a form that facilitates cell culture. KW - cell migration KW - electrospinning KW - fibers KW - neurite growth KW - polycaprolactone KW - tissue engineering Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-257535 VL - 21 IS - 7 ER - TY - JOUR A1 - Schmidt, Stefanie A1 - Abinzano, Florencia A1 - Mensinga, Anneloes A1 - Teßmar, Jörg A1 - Groll, Jürgen A1 - Malda, Jos A1 - Levato, Riccardo A1 - Blunk, Torsten T1 - Differential production of cartilage ECM in 3D agarose constructs by equine articular cartilage progenitor cells and mesenchymal stromal cells JF - International Journal of Molecular Sciences N2 - Identification of articular cartilage progenitor cells (ACPCs) has opened up new opportunities for cartilage repair. These cells may be used as alternatives for or in combination with mesenchymal stromal cells (MSCs) in cartilage engineering. However, their potential needs to be further investigated, since only a few studies have compared ACPCs and MSCs when cultured in hydrogels. Therefore, in this study, we compared chondrogenic differentiation of equine ACPCs and MSCs in agarose constructs as monocultures and as zonally layered co-cultures under both normoxic and hypoxic conditions. ACPCs and MSCs exhibited distinctly differential production of the cartilaginous extracellular matrix (ECM). For ACPC constructs, markedly higher glycosaminoglycan (GAG) contents were determined by histological and quantitative biochemical evaluation, both in normoxia and hypoxia. Differential GAG production was also reflected in layered co-culture constructs. For both cell types, similar staining for type II collagen was detected. However, distinctly weaker staining for undesired type I collagen was observed in the ACPC constructs. For ACPCs, only very low alkaline phosphatase (ALP) activity, a marker of terminal differentiation, was determined, in stark contrast to what was found for MSCs. This study underscores the potential of ACPCs as a promising cell source for cartilage engineering. KW - ACPC KW - chondroprogenitors KW - tissue engineering KW - MSC KW - agarose KW - hypoxia KW - ECM KW - co-culture KW - zonal KW - cartilage Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236180 SN - 1422-0067 VL - 21 IS - 19 ER - TY - JOUR A1 - Xu, Jietao A1 - Fahmy-Garcia, Shorouk A1 - Wesdorp, Marinus A. A1 - Kops, Nicole A1 - Forte, Lucia A1 - De Luca, Claudio A1 - Misciagna, Massimiliano Maraglino A1 - Dolcini, Laura A1 - Filardo, Giuseppe A1 - Labberté, Margot A1 - Vancíková, Karin A1 - Kok, Joeri A1 - van Rietbergen, Bert A1 - Nickel, Joachim A1 - Farrell, Eric A1 - Brama, Pieter A. J. A1 - van Osch, Gerjo J. V. M. T1 - Effectiveness of BMP-2 and PDGF-BB adsorption onto a collagen/collagen-magnesium-hydroxyapatite scaffold in weight-bearing and non-weight-bearing osteochondral defect bone repair: in vitro, ex vivo and in vivo evaluation JF - Journal of Functional Biomaterials N2 - Despite promising clinical results in osteochondral defect repair, a recently developed bi-layered collagen/collagen-magnesium-hydroxyapatite scaffold has demonstrated less optimal subchondral bone repair. This study aimed to improve the bone repair potential of this scaffold by adsorbing bone morphogenetic protein 2 (BMP-2) and/or platelet-derived growth factor-BB (PDGF-BB) onto said scaffold. The in vitro release kinetics of BMP-2/PDGF-BB demonstrated that PDGF-BB was burst released from the collagen-only layer, whereas BMP-2 was largely retained in both layers. Cell ingrowth was enhanced by BMP-2/PDFG-BB in a bovine osteochondral defect ex vivo model. In an in vivo semi-orthotopic athymic mouse model, adding BMP-2 or PDGF-BB increased tissue repair after four weeks. After eight weeks, most defects were filled with bone tissue. To further investigate the promising effect of BMP-2, a caprine bilateral stifle osteochondral defect model was used where defects were created in weight-bearing femoral condyle and non-weight-bearing trochlear groove locations. After six months, the adsorption of BMP-2 resulted in significantly less bone repair compared with scaffold-only in the femoral condyle defects and a trend to more bone repair in the trochlear groove. Overall, the adsorption of BMP-2 onto a Col/Col-Mg-HAp scaffold reduced bone formation in weight-bearing osteochondral defects, but not in non-weight-bearing osteochondral defects. KW - tissue engineering KW - regenerative medicine KW - osteochondral lesion KW - biocompatible materials KW - bone morphogenetic proteins KW - platelet-derived growth factor KW - animal model KW - weight-bearing Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-304019 SN - 2079-4983 VL - 14 IS - 2 ER -